Enfin la bonne nouvelle pour relancer la croissance ? - ACHAT vs NEUTRE - OBJECTIF : 7,6€
Le nouveau partenariat avec Apicil annoncé ce matin pourrait s’avérer transformant pour Bluelinea, tant en termes de taille que de capacité à adresser le marché. Après une année 2016 de transformation pénalisante sur le front de la croissance (-3,9% attendus), cet accord pourrait être un levier majeur pour retrouver une solide dynamique en 2017 (+22% attendus). Même si une clarification de la stratégie est nécessaire lors de la journée investisseurs du 2 février, cette annonce, combinée au recul de -24% du titre depuis 3 mois, nous conduit à relever notre opinion de NEUTRE à ACHAT, avec un objectif inchangé de 7,6€ (+15%).Bluelinea S A. Bluelinea SA is a France-based company engaged in the medical sector. Bluelinea SA specializes in designing and developing electronic surveillance and medical teleassistance systems. It offers caregiver identification and authentication badges, individual protection bracelets for newborns, and home care and treatment devices for fragile or chronically ill elderly persons. The Company cooperates with Europe-based partners, including Everon Oy/Ab and Hager group, among others.
Since 2006, Invest Securities has become one of the leading players in investment services for funds and managers, to whom we offer a global and personalised service. Our track record differentiates us and proves our leadership in numerous promising sectors like property and growth companies.
Consisting of 13 different profiles (pharmacist, engineer, financier, etc), the DNA of our financial analysis office is value added and sector expertise. Through daily monitoring and detailed analyses of companies and sectors, we seek to provide a differentiating vision of our 120 stocks followed. Our ideas are circulated every day to nearly 1,000 professionals.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.